Clinical registries have been proven as a vital tool to further research concerning rare diseases like pediatric onset inflammatory bowel disease (PIBD) as they aggregate a sufficient amount of data for a better understanding of disease phenotypes and timeline and the support of clinical trials.
Statement of the GPGE working groups CEDATA and Nutrition/Nutrition Medicine AbstactEpidemiologische und klinische Beobachtungen sowie Tiermodelle weisen auf die Ernährung als Risikofaktor für die Entwicklung einer chronisch entzündlichen Darmerkrankung (CED) hin. Die exklusive enterale Ernährungstherapie Weiterlesen
ABSTRACT – Background and Aims: Intensifying therapy for Paediatric Crohn’s Disease (CD) by early use of immunomodulators and biologics has been proposed for cases in which predictors of poor outcome (POPO) were present. We investigated therapy Weiterlesen
DATA FROM THE CEDATA GPGE REGISTRY To date, failure of the first-line medical management of Crohn’s disease (CD) in children and adolescents has been followed by escalation treatment, with administration of immunomodulators, e.g., azathioprine, or Weiterlesen
0 Kommentare